Baxter Highlights New Data At Kidney Week Indicating Sharesource Is Associated With A 77% Lower Risk Of Home Dialysis Technique Failure
Portfolio Pulse from Benzinga Newsdesk
Baxter International Inc. (BAX) has announced new data indicating that its Sharesource remote patient management (RPM) digital platform, when used with an automated peritoneal dialysis (PD) system, is associated with a 77% reduction in risk of PD technique failure. The data also shows that HDx therapy enabled by Theranova dialyzer can help reduce annual water consumption by 27% and annual electricity usage by 17%, and associated costs, in comparison with online HDF (hemodiafiltration).
November 06, 2023 | 1:32 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Baxter's new data indicating the effectiveness of its Sharesource RPM platform and HDx therapy enabled by Theranova dialyzer could potentially boost the company's reputation and market share in the kidney care sector.
The new data presented by Baxter highlights the effectiveness of its Sharesource RPM platform and HDx therapy, which could potentially attract more healthcare providers to use their products. This could lead to an increase in Baxter's revenues and potentially its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100